This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Cour Pharmaceuticals Development Company, Inc., University of Michigan. Active years: 2022-2025.
Company Filing History:
2 out of 6 
2 out of 3,511 
Years Active: 2022-2025
Title: James Herrmann: Innovator in Immunological Tolerance
Introduction
James Herrmann is a notable inventor based in Northbrook, IL (US). He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Herrmann's work focuses on enhancing immune responses and developing new therapeutic methods.
Latest Patents
Herrmann's latest patents include the development of covalent polymer-antigen conjugated particles. This invention provides compositions comprising tolerizing immune modified particles (TIMPs) and outlines methods for their use and production. The carrier polymer is covalently conjugated with antigenic peptide before particle formation, allowing for precise control over particle size and antigen encapsulation. This technology is particularly useful for eliciting the induction of immunological tolerance.
Career Highlights
Throughout his career, James Herrmann has worked with various organizations, including Cour Pharmaceuticals Development Company, Inc. and the University of Michigan. His experience in these institutions has contributed to his expertise in immunological research and development.
Collaborations
Some of Herrmann's notable coworkers include John Puisis and Ryan Pearson. Their collaborative efforts have likely played a role in advancing the research and applications of Herrmann's inventions.
Conclusion
James Herrmann's contributions to immunology through his innovative patents demonstrate his commitment to advancing medical science. His work in developing covalent polymer-antigen conjugated particles is paving the way for new therapeutic approaches in immunological tolerance.